Francois J G Vingerhoets. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antiparkinson Agents/adverse effectsAntiparkinson Agents/therapeutic useDopamine Agents/adverse effectsDopamine Agents/therapeutic useDyskinesias/diagnostic imagingDyskinesias/etiologyHumansParkinson Disease/complicationsParkinson Disease/diagnostic imagingPositron-Emission TomographyRadiopharmaceuticalsSynapses/drug effectsTetrabenazine/analogs & derivatives
Substances: See more » Antiparkinson AgentsDopamine AgentsRadiopharmaceuticalsdihydrotetrabenazineTetrabenazine
Year: 2009 PMID: 19349599 DOI: 10.1212/01.wnl.0000345658.54511.31
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910